文献速递慢性肾脏病水电解质与酸碱

对甲酚葡萄糖醛酸苷是小鼠对甲酚的主要代谢物:与对甲酚硫酸盐不同,它不促进胰岛素抵抗

p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本研究在小鼠中评估对甲酚代谢,并比较对甲酚硫酸盐(p-CS)与对甲酚葡萄糖醛酸苷(p-CG)对胰岛素敏感性的影响。结果显示,与人类不同,小鼠慢性给予对甲酚后两种结合物均蓄积;p-CG在体内外均不影响胰岛素敏感性,也不与p-CS产生协同抑制作用。

要点

  • 小鼠中对甲酚主要代谢为p-CG,与人类以p-CS为主不同。
  • p-CG在体内外均不促进胰岛素抵抗,而p-CS则促进。
  • p-CG与p-CS联合无协同抑制胰岛素信号的作用。

核心结论

  • 小鼠中对甲酚两种结合物的相对比例与人类不同,存在显著种间代谢差异。
  • p-CS而非p-CG促进CKD中的胰岛素抵抗。

研究设计与样本

  • 研究测量对照、5/6肾切除小鼠及腹腔注射对甲酚或p-CG小鼠的血清p-CS和p-CG水平。
  • 体内通过胰岛素耐受试验评估胰岛素敏感性,体外用C2C12肌细胞检测胰岛素刺激的葡萄糖摄取和PKB/Akt信号通路。

主要发现

  • 在CKD小鼠中,p-CS和p-CG均蓄积;慢性给予对甲酚后两者浓度相当,但蛋白结合率差异显著(p-CS为96%,p-CG低于6%)。
  • p-CG在体内和体外均不影响胰岛素敏感性。
  • p-CG与p-CS联合无协同抑制胰岛素信号的作用。

关键数值与推荐

  • p-CS蛋白结合率为96%,p-CG蛋白结合率低于6%。

临床怎么用

  • 在解释小鼠模型中对甲酚类尿毒症毒素的生物学效应时,需考虑种间代谢差异。
  • 靶向p-CS而非p-CG可能更有助于改善CKD相关胰岛素抵抗。

局限性

  • 研究仅在小鼠和C2C12细胞中进行,结果外推到人类需谨慎。
  • 原文未报告样本量、P值等详细统计信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of uraemic toxins in insulin resistance associated with chronic kidney disease (CKD) is gaining interest. p-Cresol has been defined as the intestinally generated precursor of the prototype protein-bound uraemic toxins p-cresyl sulphate (p-CS) as the main metabolite and, at a markedly lower concentration in humans, p-cresyl glucuronide (p-CG). The objective of the present study was to evaluate the metabolism of p-cresol in mice and to decipher the potential role of both conjugates of p-cresol on glucose metabolism. METHODS: p-CS and p-CG were measured by high performance liquid chromatography-fluorescence in serum from control, 5/6 nephrectomized mice and mice injected intraperitoneously with either p-cresol or p-CG. The insulin sensitivity in vivo was estimated by insulin tolerance test. The insulin pathway in the presence of p-cresol, p-CG and/or p-CS was further evaluated in vitro on C2C12 muscle cells by measuring insulin-stimulated glucose uptake and the insulin signalling pathway (protein kinase B, PKB/Akt) by western blot. RESULTS: In contrast to in humans, where p-CS is the main metabolite of p-cresol, in CKD mice both conjugates accumulated, and after chronic p-cresol administration with equivalent concentrations but a substantial difference in protein binding (96% for p-CS and <6% for p-CG). p-CG exhibited no effect on insulin sensitivity in vivo or in vitro and no synergistic inhibiting effect in combination with p-CS. CONCLUSIONS: The relative proportion of the two p-cresol conjugates, i.e. p-CS and p-CG, is similar in mouse, in contrast to humans, pinpointing major inter-species differences in endogenous metabolism. Biologically, the sulpho- (i.e. p-CS) but not the glucuro- (i.e. p-CG) conjugate promotes insulin resistance in CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Koppe L, Alix PM, Croze ML, et al. p-Cresyl glucuronide is a major metabolite of p-cresol in mouse: in contrast to p-cresyl sulphate, p-cresyl glucuronide fails to promote insulin resistance. Nephrol Dial Transplant. 2017. PMID: 28992089. doi:10.1093/ndt/gfx089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。